Share prices of Ipca Laboratories went up by 3.21% to Rs. 655.00 reported at BSE at 11.04 a.m. on 26 February 2008 against previous day close of Rs 634.60.
The rising share prices may have positive impact on NAV of mutual fund schemes, which holds their stake in the company. JM Healthcare Sector fund - (G) is likely to gain most as it has the highest percentage holding of the stocks of the company compared to its peer groups who have invested in the stocks of the company. JM Healthcare Sector fund - (G) was holding 10.39% of its total portfolio size invested in the stocks of the company as on 31 January 2008. The scheme holds 8619 units of the company in January 2008.
Other schemes, which likely to gain includes Franklin Pharma Fund - (G) with holding of 51669 units (7.88% of its portfolio), and Franklin India Prima Fund - (G) with 9.00 lakh units holding (4.17%) as on 31 January 2008.
No comments:
Post a Comment